journal article·2016-08-24

Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice

Shuai Li, Jian Zhang, Chao Deng, Fenghua Meng, Lin Yu, Zhiyuan Zhong

Publisher page

Abstract

In spite of their high specificity and potency, few protein therapeutics are applied in clinical cancer therapy owing to a lack of safe and efficacious delivery systems. Here, we report that redox-sensitive and intrinsically fluorescent photoclick hyaluronic acid nanogels (HA-NGs) show highly efficient loading and breast tumor-targeted delivery of cytochrome c (CC). HA-NGs were obtained from hyaluronic acid-graft-oligo(ethylene glycol)-tetrazole (HA-OEG-Tet) via inverse nanoprecipitation and catalyst-free photoclick cross-linking with l-cystine dimethacrylamide (MA-Cys-MA). HA-NGs exhibited a superb CC loading content of up to 40.6 wt %, intrinsic fluorescence (λem = 510 nm), and a small size of ca. 170 nm. Notably, CC-loaded nanogels (CC-NGs) showed a fast glutathione-responsive protein release behavior. Importantly, released CC maintained its bioactivity. MTT assays revealed that CC-NGs were highly potent with a low IC50 of 3.07 μM to CD44+ MCF-7 human breast tumor cells. Confocal microscopy observed efficient and selective internalization of fluorescent HA-NGs into MCF-7 cells. Interestingly, HA-NGs exhibited also effective breast tumor penetration. The therapeutic results demonstrated that CC-NGs effectively inhibited the growth of MCF-7 breast tumor xenografts at a particularly low dose of 80 or 160 nmol CC equiv./kg. Moreover, CC-NGs did not cause any change in mice body weight, corroborating their low systemic side effects. Redox-sensitive and intrinsically fluorescent photoclick hyaluronic acid nanogels have appeared as a "smart" protein delivery nanoplatform enabling safe, efficacious, traceable, and targeted cancer protein therapy in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, China

State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200433, China

Funding

National Natural Science Foundation of China

References (58)

Show source-provided references
1. 10.1038/nbt.304010.1038/nbt.3040 ↗
2. 10.1126/science.124114510.1126/science.1241145 ↗
3. 10.1021/cr200157d10.1021/cr200157d ↗
4. 10.1038/nrd239910.1038/nrd2399 ↗
5. 10.1038/nrc195810.1038/nrc1958 ↗
6. 10.1002/jps.2205410.1002/jps.22054 ↗
7. 10.1039/c0cs00227e10.1039/c0cs00227e ↗
8. 10.1021/mp400363z10.1021/mp400363z ↗
9. 10.1016/j.biomaterials.2012.12.03110.1016/j.biomaterials.2012.12.031 ↗
10. 10.1021/acs.biomac.5b0019310.1021/acs.biomac.5b00193 ↗
11. 10.1016/j.actbio.2014.01.01010.1016/j.actbio.2014.01.010 ↗
12. 10.1016/j.jconrel.2012.01.04310.1016/j.jconrel.2012.01.043 ↗
13. 10.1002/anie.20140476610.1002/anie.201404766 ↗
14. 10.1038/nnano.2014.20810.1038/nnano.2014.208 ↗
15. 10.1016/j.biomaterials.2012.02.01010.1016/j.biomaterials.2012.02.010 ↗
16. 10.1002/anie.20131124510.1002/anie.201311245 ↗
17. 10.1021/acsami.5b0346410.1021/acsami.5b03464 ↗
18. 10.1039/c0cc03590d10.1039/c0cc03590d ↗
19. 10.1039/C4CS00341A10.1039/C4CS00341A ↗
20. 10.1016/j.addr.2015.10.00410.1016/j.addr.2015.10.004 ↗
21. 10.1021/cr500131f10.1021/cr500131f ↗
22. 10.1016/j.jconrel.2014.08.01510.1016/j.jconrel.2014.08.015 ↗
23. 10.1016/j.nantod.2015.09.00510.1016/j.nantod.2015.09.005 ↗
24. 10.1021/bm301286h10.1021/bm301286h ↗
25. 10.1016/j.actbio.2016.01.01110.1016/j.actbio.2016.01.011 ↗
26. 10.1021/acs.langmuir.5b0464510.1021/acs.langmuir.5b04645 ↗
27. 10.1016/j.progpolymsci.2008.01.00210.1016/j.progpolymsci.2008.01.002 ↗
28. 10.1016/j.biomaterials.2014.03.00110.1016/j.biomaterials.2014.03.001 ↗
29. 10.1021/bm501091p10.1021/bm501091p ↗
30. 10.1039/C5BM00171D10.1039/C5BM00171D ↗
31. 10.1016/j.jconrel.2012.12.00810.1016/j.jconrel.2012.12.008 ↗
32. 10.1002/adfm.20150089410.1002/adfm.201500894 ↗
33. 10.1021/bm400206m10.1021/bm400206m ↗
34. 10.1039/c3cc44272a10.1039/c3cc44272a ↗
35. 10.1517/17425247.2016.111237410.1517/17425247.2016.1112374 ↗
36. 10.1016/j.jconrel.2009.09.01010.1016/j.jconrel.2009.09.010 ↗
37. 10.1002/anie.20070580510.1002/anie.200705805 ↗
38. 10.1021/bm400637s10.1021/bm400637s ↗
39. 10.1002/pola.2059910.1002/pola.20599 ↗
40. 10.1016/j.biomaterials.2016.01.04910.1016/j.biomaterials.2016.01.049 ↗
41. 10.1021/am505824d10.1021/am505824d ↗
42. 10.1002/adfm.20150274210.1002/adfm.201502742 ↗
43. 10.1039/C4SM01746C10.1039/C4SM01746C ↗
44. 10.1016/j.actbio.2015.04.03010.1016/j.actbio.2015.04.030 ↗
45. 10.1039/c2nr33134a10.1039/c2nr33134a ↗
46. 10.1016/j.jconrel.2011.01.03010.1016/j.jconrel.2011.01.030 ↗
47. 10.1016/j.biomaterials.2011.11.02210.1016/j.biomaterials.2011.11.022 ↗
48. 10.1016/j.actbio.2014.10.00210.1016/j.actbio.2014.10.002 ↗
49. 10.1016/j.jconrel.2015.01.01210.1016/j.jconrel.2015.01.012 ↗
50. 10.1016/j.jconrel.2015.02.00810.1016/j.jconrel.2015.02.008 ↗
51. 10.1021/acsami.5b1147110.1021/acsami.5b11471 ↗
52. 10.1158/0008-5472.CAN-12-456110.1158/0008-5472.CAN-12-4561 ↗
53. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
54. 10.1016/j.nantod.2012.08.00510.1016/j.nantod.2012.08.005 ↗
55. 10.1002/ppsc.20140014010.1002/ppsc.201400140 ↗
56. 10.1016/j.jconrel.2015.08.05810.1016/j.jconrel.2015.08.058 ↗
57. 10.1002/adma.20140449810.1002/adma.201404498 ↗
58. 10.1016/j.nantod.2012.12.00310.1016/j.nantod.2012.12.003 ↗